Certain Options of Poseida Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 6-JAN-2021. These Options will be under lockup for 181 days starting from 9-JUL-2020 to 6-JAN-2021. Details: The company, executive officers, directors and other existing security holders have agreed not to sell or transfer any common stock or securities convertible into, exchangeable for, exercisable for, or repayable with common stock, for 180 days after the date of this prospectus without first obtaining the written consent of BofA Securities, Inc. and Piper Sandler & Co.